CJC-1295 No DAC
An educational overview of CJC-1295 No DAC, a growth hormone-releasing hormone (GHRH) analog investigated for growth hormone physiology, endocrine signaling, IGF-1 biology, and body composition research.
Peptide Class
GHRH AnalogCategory
Growth HormonePrimary Target
GHRH ReceptorResearch Interest
Very HighResearch Snapshot
Overview
CJC-1295 No DAC is a synthetic growth hormone-releasing hormone (GHRH) analog commonly studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation.
Researchers investigate its effects on growth hormone physiology, IGF-1 signaling, body composition, recovery, and endocrine function in laboratory settings.
How It Works
CJC-1295 No DAC binds to GHRH receptors in the pituitary, promoting pulsatile growth hormone release. Scientists continue studying how this influences downstream IGF-1 production and metabolic physiology.
Areas of Scientific Interest
Related Compounds
FAQ
What is the difference between CJC-1295 No DAC and CJC-1295 DAC?
The two compounds are researched separately because the addition of Drug Affinity Complex (DAC) changes pharmacokinetic properties, making them distinct research compounds.
Does this page provide dosage information?
No. Cloud Peptides does not provide dosage recommendations or administration guidance.
What is this page for?
This page summarizes publicly available scientific literature for educational purposes only.
Research Use Only
This page summarizes published scientific literature for educational purposes only.
Cloud Peptides does not provide medical advice, treatment recommendations, or dosage information.
All products are intended strictly for laboratory research purposes only and are not for human consumption.